Cynthia A Sirard

Title: Cynthia A. Sirard: Innovator in Cancer Treatment

Introduction

Cynthia A. Sirard is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 2 patents, her work focuses on utilizing biomarkers for effective cancer therapies.

Latest Patents

Cynthia's latest patents include a method for using beta-catenin as a biomarker for treating various cancers. This method involves administering an effective amount of an anti-Dkk-1 antibody or its antigen-binding fragment to subjects diagnosed with esophageal cancer, uterine cancer, liver cancer, or cholangiocarcinoma. The treatment is specifically designed for patients with a constitutively activating mutation of the beta-catenin protein.

Career Highlights

Cynthia A. Sirard has established herself as a key figure in the medical research community. Her work at Leap Therapeutics, Inc. has been instrumental in advancing cancer treatment methodologies. She is dedicated to improving patient outcomes through innovative therapeutic approaches.

Collaborations

Cynthia collaborates with notable professionals in her field, including her coworker Michael H. Kagey. Their combined expertise contributes to the development of groundbreaking cancer therapies.

Conclusion

Cynthia A. Sirard's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the medical field. Her dedication to research and collaboration continues to pave the way for advancements in cancer therapies.